Kopran Ltd is an international pharmaceutical marketing and manufacturing company dedicated to supplying high-quality Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs) to the global market. With two WHO GMP approved factories, Kopran Ltd produces a wide range of pharmaceutical products, including APIs for various therapeutic categories such as Anti-hypertensive, Macrolides, Neuromodulators, Cephalosporins, Carbapenems, and Oncology. The company also manufactures Finished Dosage Forms in diverse areas including Gastroenterology, Anthelmintics, Central Nervous System, Pain management, Anti-allergies, Anti-asthmatics, Anti-Infectives, Penicillins, Cardiovascular, Antiprotozoal, Oncology, Anti-Diabetics, Erectile Dysfunction, and Macrolides. Their facility in Khopoli for FDFs is approved by TGA, MHRA, and MCC, while their API facility in Mahad is WHO GMP accredited. Kopran Ltd exports to major markets in Europe, South-East Asia, and Latin America, ensuring the delivery of high-quality formulations and active pharmaceutical ingredients worldwide.

Services include:
- APIs (Active Pharmaceutical Ingredients)
- Contract Development and Manufacturing (CDMO)

Kopran Limited is committed to excellence in the pharmaceutical industry, continuously expanding its product offerings and ensuring international quality standards. For more information, please reach out to [email protected].